1. Dr. Paul M. Matthews. Multiple sclerose en hersen-MRI-expert. Biografie. 0
Dr. Paul M. Matthews, MD, explains his distinguished career in translational neuroscience. He holds prestigious academic and research leadership positions at Imperial College London.
▶⏸
2. Multiple sclerose. Hoe verlies van neuronen de prognose beïnvloedt. 1
Dr. Paul Matthews, MD, explains how axonal and neuronal loss drives disease progression. He details the paradigm-shifting research that redefined MS as a neurodegenerative condition....
▶⏸
3. Multiple Sclerose behandeling. Rituximab, Quilizimab, lymfevaten van de hersenen Deel 1 van 3. 7
Dr. Paul Matthews, MD, explains recent breakthroughs in personalized medicine. He highlights the landmark rituximab trial that transformed MS immunology by targeting B-cells.
▶⏸
4. Multiple Sclerose diagnose en prognose. Hersen-MRI en PET-CT. Deel 1 van 2. 11
Dr. Paul Matthews, MD, explains how advanced MRI and PET CT technologies are revolutionizing diagnosis and prognosis. He details the use of optical coherence tomography...
▶⏸
5. Vroeg stadium multiple sclerose. Neurodegeneratie en vooruitgang tot invaliditeit. Deel 1. 2
Dr. Paul Matthews, MD, explains how axonal loss begins early in MS and drives permanent disability. He details how MRI techniques can measure brain volume...
▶⏸
6. Multiple Sclerose behandeling. Neuromyelitis optica. Tysabri. Precisie geneeskunde. Deel 2 van 3. 8
Dr. Paul Matthews, MD, explains major breakthroughs in personalized medicine for MS. He details how genetic research confirmed MS as a primary autoimmune disease.
▶⏸
7. Multiple Sclerose diagnose en prognose. Op antilichamen gebaseerde MRI. Kwantitatieve MRI. Deel 2 van 2. 12
Dr. Paul Matthews, MD, explains how MRI technology is rapidly evolving. He details advancements in speed, sensitivity, and novel contrast agents.
▶⏸
8. Vroeg stadium multiple sclerose. Neurodegeneratie en vooruitgang tot invaliditeit. Deel 2. 3
Dr. Paul Matthews, MD, explains how early brain damage in MS does not immediately cause disability. He details the brain's remarkable capacity for adaptive repair...
Dr. Paul Matthews, MD, explains the heterogeneity of multiple sclerosis as a clinical syndrome. He details how patients experience vastly different disease courses, from benign...
Dr. Paul Matthews, MD, explains how neuromyelitis optica (NMO) was redefined as a distinct disease from MS. He details the role of the Aquaporin-4 antibody...
▶⏸
11. Multiple sclerose. Herstel van terugval. Hoe de neurologische functie te verbeteren? 6
Dr. Paul Matthews, MD, explains how neurological function recovers after a relapse. He details the brain's remarkable plasticity and redundancy. Recovery mechanisms include neuronal repair,...
▶⏸
12. Eerste symptomen van multiple sclerose. Welke leeftijd bij aanvang betekent voor de behandeling en prognose van multiple sclerose. 10
Dr. Paul Matthews, MD, explains how age of onset impacts disease progression and treatment. His sophisticated MRI analysis reveals older patients experience more aggressive neurodegeneration....
▶⏸
13. Multiple Sclerose behandeling. 11 nieuwe mediations. Maar hoe kies je de juiste mediation? Deel 3 van 3. 9
Dr. Paul Matthews, MD, explains how personalized medicine is advancing treatment. He details the importance of real-world clinical effectiveness research.
▶⏸
14. Patiënt-artsrelatie in het tijdperk van precisiegeneeskunde. 13
Dr. Paul Matthews, MD, explains the evolution of the patient-doctor relationship. He details the shift from a service model to a collaborative partnership.
▶⏸
15. Gestratificeerde geneeskunde. Precisiegeneeskunde voor de beste behandeling van multiple sclerose. Inschatting van de prognose. 14
Dr. Paul Matthews, MD, explains how stratified medicine improves treatment. He details how grouping patients by disease characteristics and prognosis informs therapy choices.
▶⏸
16. Precisie Farmacologie. Ontdekking van medicijnen. Gepersonaliseerde behandeling van multiple sclerose. 15
Dr. Paul Matthews, MD, explains how precision pharmacology revolutionizes drug development. He details the concept of targeting the right molecule at the right time and...
Verfijn uw behandelplan tot in de puntjes door een panel van 3 tot 10+ topartsen die perfect bij u passen.
